Extended-Release Mirapex Approved for Parkinson's Disease (HealthDay)

Links shared publicly online about this topic.

  • 1,356
    total visits

Extended-Release Mirapex Approved for Parkinson's Disease (HealthDay)

links.assetize.com

Assetize allows publishers to brand and monetize shared links.

View full resource at links.assetize.com

Tags: Parkinson's Disease, Parkinson's Disease Medication, Neuropathic Pain Medication, Disease and Condition, Mirapex

  • Share

Most Recently Shared on February 25, 2010 at 11:47 am By:

HealthSociety Healthy Society

Extended-Release Mirapex Approved for Parkinson's Disease (HealthDay) http://bit.ly/97wajM

2 years ago...

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 26, 2010 at 11:38 am By:

Parkinsons_News News-Medical.Net Health News

Parkinson's Disease: FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD: Boehringer Ingelheim... http://bit.ly/9ct9qR

2 years ago...

Once-Daily MIRAPEX ER Now Approved By FDA For Both Early And Advanced Parkinson's Disease

medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tabletView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 24, 2010 at 12:37 pm By:

medical_tweets medical_tweets Health News

Once-Daily MIRAPEX ER Now Approved By FDA For Both Early And Advanced Parkinson's Disease Boehringer Ingelheim Pharma.. http://bit.ly/ahPstx

2 years ago...

Mirapex ER approved for advanced Parkinson's Disease - ONA

oncologynurseadvisor.com — “The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer Ingelheim) for the signs and symptoms of advanced idiopathic Parkinson--™s disease (PD).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 23, 2010 at 3:59 pm By:

Extended-Release Mirapex Approved for Parkinson’s Disease - Tom Heston

tomheston.com — “Extended-Release Mirapex Approved for Parkinson’s Disease - Tom HestonView full resource at tomheston.com

  • View Related
  • Share

Most Recently Shared on February 26, 2010 at 6:25 am By:

tomheston Tom Heston, MD Doctor, Family Medicine Doctor, and Physician

Extended-Release Mirapex Approved for Parkinson’s Disease http://bit.ly/98Un6R

2 years ago...

Extended-Release Mirapex Approved for Parkinson's Disease - Yahoo! News

us.rd.yahoo.com — “WEDNESDAY, Feb. 24 (HealthDay News) -- Mirapex ER (pramipexole dihydrochloride extended-release) has been approved by the U.S. Food and Drug Administration as a once-daily option to treat early Parkinson's disease, drug maker Boehringer Ingelheim said in a news release.View full resource at us.rd.yahoo.com

  • View Related
  • Share

Most Recently Shared on February 24, 2010 at 5:28 pm By:

HealthNewsNow Health News Now Health News

Extended-Release Mirapex Approved for Parkinson's Disease (HealthDay) http://bit.ly/a2AFKd

2 years ago...

Medical News: FDA Okays Once-Daily Parkinson's Drug - in Neurology, Parkinson's Disease from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA has approved an extended release version of pramipexole (Mirapex ER) for patients with early Parkinson's disease.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on February 24, 2010 at 4:07 pm By:

medical_tweets medical_tweets Health News

FDA Okays Once-Daily Parkinson's Drug WASHINGTON (MedPage Today) -- The FDA has approved an extended release version .. http://bit.ly/aP4x1P

2 years ago...

FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease

medicalnewstoday.com — “Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new onView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 23, 2010 at 2:11 pm By:

mnt_parkinsons MNT Parkinson's News Health News

FDA Approves Once-Daily MIRAPEX ER For The Treatment Of Early Parkinson's Disease http://mnt.to/3xY5 #parkinsons

2 years ago...

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 23, 2010 at 10:12 am By:

Parkinsons_News News-Medical.Net Health News

Parkinson's Disease: Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of ear... http://bit.ly/c33J2g

2 years ago...

Mirapex ER approved for early Parkinson's disease - ONA

oncologynurseadvisor.com — “The FDA has approved Mirapex ER (pramipexole dihydrochloride extended-release tablets, from Boehringer-Ingelheim Pharmaceuticals) as a treatment for the signs and symptoms of early idiopathic Parkinson--™s disease.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on February 22, 2010 at 5:44 pm By:

Advertisement